WO2008065544A3 - Prédicteurs génétiques d'un risque de diabète sucré de type 2 - Google Patents

Prédicteurs génétiques d'un risque de diabète sucré de type 2 Download PDF

Info

Publication number
WO2008065544A3
WO2008065544A3 PCT/IB2007/004361 IB2007004361W WO2008065544A3 WO 2008065544 A3 WO2008065544 A3 WO 2008065544A3 IB 2007004361 W IB2007004361 W IB 2007004361W WO 2008065544 A3 WO2008065544 A3 WO 2008065544A3
Authority
WO
WIPO (PCT)
Prior art keywords
risk
type
diabetes mellitus
t2dm
genetic predictors
Prior art date
Application number
PCT/IB2007/004361
Other languages
English (en)
Other versions
WO2008065544A2 (fr
Inventor
Constantin Polychronakos
Rob Sladek
Philippe Froguel
Original Assignee
Univ Mcgill
Constantin Polychronakos
Rob Sladek
Philippe Froguel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Constantin Polychronakos, Rob Sladek, Philippe Froguel filed Critical Univ Mcgill
Publication of WO2008065544A2 publication Critical patent/WO2008065544A2/fr
Publication of WO2008065544A3 publication Critical patent/WO2008065544A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés d'analyse d'individus étant à risque pour le développement d'un diabète sucré de Type 2 (T2DM). Des acides nucléiques obtenus à partir d'échantillons biologiques d'individus souffrant de T2DM ont été analysés et des SNP associés aux gènes de T2DM ont été découverts. De plus, des SNP en déséquilibre de liaison avec des gènes de T2DM sont décrits.
PCT/IB2007/004361 2006-09-11 2007-09-11 Prédicteurs génétiques d'un risque de diabète sucré de type 2 WO2008065544A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84358606P 2006-09-11 2006-09-11
US60/843,586 2006-09-11

Publications (2)

Publication Number Publication Date
WO2008065544A2 WO2008065544A2 (fr) 2008-06-05
WO2008065544A3 true WO2008065544A3 (fr) 2009-03-19

Family

ID=39468332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004361 WO2008065544A2 (fr) 2006-09-11 2007-09-11 Prédicteurs génétiques d'un risque de diabète sucré de type 2

Country Status (1)

Country Link
WO (1) WO2008065544A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2493916B1 (fr) 2009-10-26 2016-06-08 Externautics S.p.A. Marqueurs associés avec des tumeurs pulmonaires et leur utilisation
EP2494351B1 (fr) 2009-10-26 2016-06-08 Externautics S.p.A. Marqueurs de tumeurs du rectum et du côlon, et leurs méthodes d'utilisation
EP2494361B2 (fr) 2009-10-26 2019-01-09 Externautics S.p.A. Marqueurs de tumeurs des ovaires et leurs méthodes d'utilisation
CN104395479B (zh) * 2012-01-27 2019-03-15 香港中文大学 糖尿病的生物标志物
BR112022017770A2 (pt) * 2020-03-06 2022-11-29 Denovo Biopharma Llc Polinucleotídeo isolado; painel de polinucleotídeos isolados; kit que compreende o polinucleotídeo isolado ou painel; microarranjo; reagente; kit que compreende o reagente; kit que compreende o polinucleotídeo isolado ou painel; método de diagnóstico complementar; método para classificar um indivíduo para elegibilidade para um tratamento; método para rastrear um indivíduo ou uma população de indivíduos para um tratamento; método para monitorar um indivíduo durante um tratamento; método para identificar um alvo de fármaco; método para o tratamento de doença ou transtorno do sistema nervoso central (snc) em um indivíduo; uso

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004042358A2 (fr) * 2002-11-01 2004-05-21 Decode Genetics Ehf. Gene slit-3 du diabete de type ii humain situe sur le chromosome 5q35
FR2847263A1 (fr) * 2002-11-18 2004-05-21 Commissariat Energie Atomique Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
US20050147987A1 (en) * 2000-09-08 2005-07-07 Applera Corporation (Ny) Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof
WO2006022634A1 (fr) * 2004-07-22 2006-03-02 Sequenom, Inc. Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
WO2008065682A2 (fr) * 2006-11-30 2008-06-05 Decode Genetics Ehf. Variantes génétiques de susceptibilité au diabète mellitus de type 2

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050147987A1 (en) * 2000-09-08 2005-07-07 Applera Corporation (Ny) Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof
WO2004042358A2 (fr) * 2002-11-01 2004-05-21 Decode Genetics Ehf. Gene slit-3 du diabete de type ii humain situe sur le chromosome 5q35
FR2847263A1 (fr) * 2002-11-18 2004-05-21 Commissariat Energie Atomique Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
WO2006022634A1 (fr) * 2004-07-22 2006-03-02 Sequenom, Inc. Méthodes d’identification du risque d’apparition de diabètes de type ii et traitements associés
WO2008065682A2 (fr) * 2006-11-30 2008-06-05 Decode Genetics Ehf. Variantes génétiques de susceptibilité au diabète mellitus de type 2

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE ENTREZ PROTEIN [online] NCBI; 18 May 2005 (2005-05-18), "CAH72347. Reports calmodulin bindin...[gi:55665770]", XP002497998, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV/ENTREZ/VIEWER.FCGI?DB=PROTEIN Database accession no. 55665770 *
DATABASE ENTREZ PROTEIN [online] NCBI; 7 May 2008 (2008-05-07), "CAH72347. Reports calmodulin bindin...[gi:55665770]", XP002497997, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV/ENTREZ/VIEWER.FCGI?DB=PROTEIN Database accession no. 55665770 *
DATABASE PROBE [online] ncbi; 22 February 2006 (2006-02-22), "rs13266634", XP002509338, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. Pr003758580.1 *
DATABASE SNP [online] NCBI; 10 October 2003 (2003-10-10), "rs1193179", XP002497772, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. rs1193179 *
DATABASE SNP [online] NCBI; 13 September 2004 (2004-09-13), "rs3266634", XP002509337, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. rs13266634 *
DIABETES GENETICS INITIATIVE OF BROAD INSTITUTE OF HARVARD AND MIT, LUND UNIVERSITY, AND NOVARTIS INSTITUTES OF BIOMEDICAL RESEARC: "Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.", SCIENCE (NEW YORK, N.Y.) 1 JUN 2007, vol. 316, no. 5829, 1 June 2007 (2007-06-01), pages 1331 - 1336, XP002509336, ISSN: 1095-9203 *
GRANT STRUAN F A ET AL: "Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes", NATURE GENETICS, NATURE PUBLISHING GROUP, NEW YORK, US, vol. 38, no. 3, 1 March 2006 (2006-03-01), pages 320 - 323, XP009096714, ISSN: 1061-4036 *
KANG EUN SEOK ET AL: "The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes.", May 2005, DIABETES CARE MAY 2005, VOL. 28, NR. 5, PAGE(S) 1139 - 1144, ISSN: 0149-5992, XP002496473 *
SLADEK ROBERT ET AL: "A genome-wide association study identifies novel risk loci for type 2 diabetes", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 445, no. 7130, 22 February 2007 (2007-02-22), pages 881 - 885, XP002465137, ISSN: 0028-0836 *
STEPHANE CAUCHI ET AL: "Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study", 22 January 2008, JOURNAL OF MOLECULAR MEDICINE, SPRINGER, BERLIN, DE, PAGE(S) 341 - 348, ISSN: 1432-1440, XP019576423 *

Also Published As

Publication number Publication date
WO2008065544A2 (fr) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2006134154A3 (fr) Haplotype de gene enpp1 (pc-1) associe au risque de developper une obesite et un diabete de type 2 et applications correspondantes
WO2007038670A3 (fr) Troubles de la regulation de la glycemie :methodes et depistage et traitement
TW200745556A (en) Biomarkers for liver fibrotic injury
WO2008048119A3 (fr) Procédés d'analyse des polymorphismes, et utilisations
WO2005087953A3 (fr) Polymorphismes genetiques associes a des maladies coronariennes, procedes de detection et utilisations
WO2008122670A3 (fr) Gène tnfrsf10b de susceptibilité au diabète chez l'homme
WO2007039290A3 (fr) Methodes et acides nucleiques pour l'analyse d'expression genique associee au pronostic de troubles de proliferation cellulaire
WO2007034221A3 (fr) Pronostic et cible de la therapie de cancer
WO2007070280A3 (fr) Utilisation de polymorphismes de deletion pour predire, prevenir et controler l'histoincompatibilite
WO2009059317A3 (fr) Prédiction d'amd avec snps à l'intérieur ou près de c2, facteur b, plekha1, htra1, prelp ou loc387715
WO2003012046A3 (fr) Polymorphisme du gene stk15 (stk6) et methodes de determination du risque de cancer
WO2004046098A3 (fr) Technique de prevision de maladies auto-immunes
WO2005083127A3 (fr) Polymorphismes genetiques associes a l'accident vasculaire cerebral, methodes de detection et utilisations correspondantes
EP1985715A3 (fr) ESR1 et cancer des cervicales
WO2006127294A3 (fr) Méthodes de diagnostic ou de pronostic d'une maladie à début tardif
WO2008008553A3 (fr) Polymorphismes génétiques associés à la maladie d'alzheimer, leurs méthodes de détection et leurs applications
GB0500996D0 (en) Detection method and materials therefor
WO2007050705A3 (fr) Polymorphismes genetiques associes a la maladie d'alzheimer, ainsi leurs methodes de detection et d'utilisation
WO2008136989A3 (fr) Polymorphismes géniques affectant les troubles associés à sod2 et utilisations
WO2008065544A3 (fr) Prédicteurs génétiques d'un risque de diabète sucré de type 2
WO2006110748A3 (fr) Gene de reponse au complement 32 (rgc-32) lors d'une maladie
WO2005110039A3 (fr) Polymorphismes genetiques associes a des maladies vasculaires, procedes de detection et utilisations de ceux-ci
WO2005034737A3 (fr) Diagnostic et traitement de troubles du reticulum endoplasmique
WO2006063703A8 (fr) Polymorphisme a simple nucleotide (snp)
WO2006099365A3 (fr) Polymorphismes genetiques associes a des maladies cardiaques coronariennes, methodes de detection et d'utilisation desdits polymorphismes

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07866630

Country of ref document: EP

Kind code of ref document: A2